 |
|
Cerebrospinal Fluid Carcinoembryonic Antigen in Patients With Metastatic and Nonmetastatic Neurological Diseases
Albert Twijnstra, MD;
Willem J. Nooyen, PhD;
Anton P. van Zanten, MSc;
Augustinus A. M. Hart;
Bram W. Ongerboer de Visser, MD
Arch Neurol. 1986;43(3):269-272.
Abstract
• Cerebrospinal fluid (CSF) carcinoembryonic antigen (CEA) values were determined in 200 patients suffering from various neurological diseases. We found no relationship between CEA levels and age or sex. A positive test was defined as an upper limit of at least 4.0 ng/mL of CEA. We found raised CSF CEA levels in patients with leptomeningeal spread from carcinoma, but not in patients with leptomeningeal metastases from lymphoma. We also found high values of CSF CEA in three of 21 patients with epidural metastases and in two of 28 patients with cerebral metastases from solid tumors. Comparison was made with the CSF levels of total protein, glucose, and lactate dehydrogenase. The sensitivity of the CSF CEA determination in patients for the presence of leptomeningeal involvement of cancer is 31% and the specificity is 90%.
Author Affiliations
From the Clinical Division of the Netherlands Cancer Institute, Amsterdam (Drs Twijnstra, Nooyen, Hart, and Ongerboer de Visser); and the Department of Clinical Chemistry, Municipal Hospital Slotervaart, Amsterdam (Dr van Zanten).
Footnotes
Accepted for publication July 20, 1985.
Reprints not available.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Leptomeningeal metastasis from an intracranial epidermoid cyst
Khan et al.
Neurology 2001;56:1419-1420.
FULL TEXT
|
